Your browser doesn't support javascript.
loading
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines.
Giliberto, Mariaserena; Santana, Leonardo Miranda; Holien, Toril; Misund, Kristine; Nakken, Sigve; Vodak, Daniel; Hovig, Eivind; Meza-Zepeda, Leonardo A; Coward, Eivind; Waage, Anders; Taskén, Kjetil; Skånland, Sigrid S.
Afiliação
  • Giliberto M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Santana LM; K.G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Holien T; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Misund K; K.G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Nakken S; Oslo Centre for Biostatistics and Epidemiology, University of Oslo, Oslo, Norway.
  • Vodak D; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Hovig E; Department of Hematology, St. Olav's University Hospital, Trondheim, Norway.
  • Meza-Zepeda LA; Department of Immunology and Transfusion Medicine, St. Olav's University Hospital, Trondheim, Norway.
  • Coward E; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Waage A; Norwegian Cancer Genomics Consortium, Oslo University Hospital, Oslo, Norway.
  • Taskén K; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Skånland SS; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Front Oncol ; 12: 1040730, 2022.
Article em En | MEDLINE | ID: mdl-36523963

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Noruega